Mental Health in Non-Oncologic Urology Patients
This article is a literature review of mental health concerns in non-oncologic urology patients. Pathologies represented in this review include Peyronie’s Disease (PD), erectile dysfunction (ED), urinary incontinence and urinary tract infections (UTI), infertility, benign prostatic hyperplasia (BPH), kidney stones, and urinary retention. While there has been great interventional focus as of late for urogenitary malignancies (i.e. prostate cancer awareness with the Movember campaign), literature studies and intervention focused on non-oncologic urology patients has been limited. As such, we conducted a review on urology patients with non-oncologic pathologies as an effort to increase clinician awareness of mental health concerns among such patients, increase the comfort level for clinician communication on socially sensitive topics surrounding pathologies, and review ongoing interventions conducted within these pathologies. We outlined different ongoing Mental Health Illness (MHI) needs and treatments for various pathologies. Patients with non-cancerous urologic pathologies had lower quality of life and higher incidence of MHI than the general population. As such, in line with the American Urological Association recommendations, psychological and social support from peers, therapists, and healthcare providers further prove to be crucial for some subpopulations. The review also yielded pathology specific interventions such as group therapy for ED patients. Given the higher incidence of MHI in the patient population after the Covid-19 pandemic, MHI awareness in the sphere of non-oncologic urology treatment continues to be crucial when creating a collaborative treatment platform for patients.
1. Volkert J, Schulz H, Harter M, Wlodarczyk O, Andreas S. The prevalence of mental disorders in older people in Western countries- a meta-analysis.Ageing Research Reviews. 2013;12(1):339-353. doi:10.1016/j.arr.2012.09.004
2. Hisham IN, Townsend G, Gillard S, Debnath B, Sin J. COVID-19: the perfect vector for a mental health epidemic.BJPsych Bull. 2021;45(6):332-338. doi:10.1192/bjb.2020.60
3. Cooke JE, Eirich R, Racine N, Madigan S. Prevalence of posttraumatic and general psychological stress during COVID-19: A rapid review and meta-analysis.Psychiatry Research. 2020;292:113347. doi:10.1016/j.psychres.2020.113347
4. Shorey S, Ng ED, Wong CHJ. Global prevalence of depression and elevated depressive symptoms among adolescents: A systematic review and meta-analysis.British J Clinic Psychol. 2022;61(2):287-305. doi:10.1111/bjc.12333
5. Stuntz M, Perlaky A, des Vignes F, Kyriakides T, Glass D. The Prevalence of Peyronie's Disease in the United States: A Population-Based Study.PLoS ONE. 2016;11(2):e0150157. doi:10.1371/journal.pone.0150157
6. Brand WO. Peyronie's Disease: Diagnosis and medical management.In: Post T, ed. UpToDate. UpToDate; 2022. Accessed May 28, 2022. http://www.uptodate.com
7. Terrier JE, Nelson CJ. Psychological aspects of Peyronie's disease.Transl Androl Urol. 2016;5(3):290-295. doi:10.21037/tau.2016.05.14
8. Gelbard MK, Dorey F, James K. The natural history of Peyronie's disease.J Urol. 1990;144(6):1376-1379. doi:10.1016/s0022-5347(17)39746-x
9. Smith JF, Walsh TJ, Conti SL, Turek P, Lue T. Risk factors for emotional and relationship problems in Peyronie's disease.J Sex Med. 2008;5(9):2179-2184. doi:10.1111/j.1743-6109.2008.00949.x
10. Nelson CJ, Diblasio C, Kendirci M, Hellstrom W, Guhring P, Mulhall JP. The Chronology of Depression and Distress in Men with Peyronie's Disease.The Journal of Sexual Medicine. 2008;5(8):1985-1990. doi:10.1111/j.1743-6109.2008.00895.x
11. Kuja-Halkola R, Henningsohn L, D'Onofrio BM, et al. Mental Disorders in Peyronie's Disease: A Swedish Cohort Study of 3.5 Million Men.Journal of Urology. 2021;205(3):864-870. doi:10.1097/ju.0000000000001426
12. Zachalski W, Krajka K, Matuszewski M. Evaluation of the Treatment of Congenital Penile Curvature Including Psychosexual Assessment.The Journal of Sexual Medicine. 2015;12(8):1828-1835. doi:10.1111/jsm.12933
13. Soave A, Laurich S, Dahlem R, et al. Negative Self-Perception and Self-Attitude of Sexuality Is a Risk Factor for Patient Dissatisfaction Following Penile Surgery with Small Intestinal Submucosa Grafting for the Treatment of Severe Peyronie's Disease.Journal of Clinical Medicine. 2019;8(8):1121. doi:10.3390/jcm8081121
14. Ferrini MG, Gonzalez-Cadavid NF, Rajfer J. Aging related erectile dysfunction-potential mechanism to halt or delay its onset.Transl Androl Urol. 2017;6(1):20-27. doi:10.21037/tau.2016.11.18
15. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and Its Medical and Psychosocial Correlates: Results of the Massachusetts Male Aging Study.Journal of Urology. 1994;151(1):54-61. doi:10.1016/s0022-5347(17)34871-1
16. Araujo AB, Mohr BA, McKinlay JB. Changes in Sexual Function in Middle-Aged and Older Men: Longitudinal Data from the Massachusetts Male Aging Study.JAm Geriatr Soc. 2004;52(9):1502-1509. doi:10.1111/j.0002-8614.2004.52413.x
17. Laumann EO, Paik A, Rosen RC. Sexual Dysfunction in the United States.JAMA. 1999;281(6):537. doi:10.1001/jama.281.6.537
18. Bacon CG, Mittleman MA, Kawachi I, Giovannucci E, Glasser DB, Rimm EB. Sexual Function in Men Older Than 50 Years of Age: Results from the Health Professionals Follow-up Study.Ann Intern Med. 2003;139(3):161. doi:10.7326/0003-4819-139-3-200308050-00005
19. Raymond CR, Khera M. Epidemiology and etiologies of male sexual dysfunction.
In: Post T, ed. UpToDate. UpToDate; 2022. Accessed June 5, 2022. http://www.uptodate.com
20. Krane RJ, Goldstein I, de Tejada IS. Impotence.N EnglJMed. 1989;321(24):1648-1659. doi:10.1056/nej m198912143212406
21. Karacan I, Williams R, Thornby J, Salis P. Sleep-related penile tumescence as a function of age.
American Journal of Psychiatry. 1975;132(9):932-937. doi:10.1176/ajp.132.9.932
22. Melehan KL, Hoyos CM, Hamilton GS, et al. Randomized Trial of CPAP and Vardenafil on Erectile and Arterial Function in Men With Obstructive Sleep Apnea and Erectile Dysfunction.The Journal of Clinical Endocrinology& Metabolism. 2018;103(4):1601-1611. doi:10.1210/jc.2017-02389
23. Kedia GT, Uckert S, Tsikas D, Becker AJ, Kuczyk MA, Bannowskiy A. The Use of Vasoactive Drugs in the Treatment of Male Erectile Dysfunction: Current Concepts.Journal of Clinical Medicine. 2020;9(9):2987. doi:10.3390/jcm9092987
24. Melman R. Pathophysiology of Erectile Dysfunction.Mol Urol. 1999;3(2):87-102.
25. Kaiser DR, Billups K, Mason C, Wetterling R, Lundberg JL, Bank AJ. Impaired brachial artery endothelium-dependent and-independent vasodilation in men with erectile dysfunction and no other clinical cardiovascular disease.JAm Coll Cardiol. 2004;43(2):179-184. doi:10.1016/j.jacc.2003.07.042
26. DeLay KJ, Haney N, Hellstrom WJ. Modifying Risk Factors in the Management of Erectile Dysfunction: A Review.World J Mens Health. 2016;34(2):89-100. doi:10.5534/wjmh.2016.34.2.89
27. Tan HM, Tong SF, Ho CCK. Men's Health: Sexual Dysfunction, Physical, and Psychological Health-Is There a Link?The Journal of Sexual Medicine. 2012;9(3):663-671. doi:10.1111/j.1743-6109.2011.02582.x
28. Korfage IJ, Pluijm S, Roobol M, Dohle GR, Schrder FH, Essink-Bot ML. Erectile Dysfunction and Mental Health in a General Population of Older Men.The Journal of Sexual Medicine. 2009;6(2):505-512. doi:10.1111/j.1743-6109.2008.01111.x
29. Low WY, Khoo EM, Tan HM, Hew FL, Teoh SH. Depression, hormonal status and erectile dysfunction in the aging male: results from a community study in Malaysia.The Journal of Men's Health & Gender. 2006;3(3):263-270. doi:10.1016/j.jmhg.2006.02.007
30. Sugimori H, Yoshida K, Tanaka T, et al. Relationships between Erectile Dysfunction, Depression, and Anxiety in Japanese Subjects.The Journal of Sexual Medicine. 2005;2(3):390-396. doi:10.1111/j.1743-6109.2005.20354.x
31. Calzo JP, Austin SB, Charlton BM, et al. Erectile Dysfunction in a Sample of Sexually Active Young Adult Men from a U.S. Cohort: Demographic, Metabolic and Mental Health Correlates.Journal of Urology. 2021;205(2):539-544. doi:10.1097/ju.0000000000001367
32. Liu Q, Zhang Y, Wang J, et al. Erectile Dysfunction and Depression: A Systematic Review and Meta-Analysis.
The Journal of Sexual Medicine. 2018;15(8):1073-1082. doi:10.1016/j.jsxm.2018.05.016
33. Herman JB, Brotman AW, Pollack MH, Falk WE, Biederman J, Rosenbaum JF. Fluoxetine-induced sexual dysfunction.J Clin Psychiatry. 1990;51(1):25-27.
34. Melnik T, Soares B, Nasello AG. Psychosocial interventions for erectile dysfunction.
Cochrane Database of Systematic Reviews. 2007;2010(1). doi:10.1002/14651858.cd004825.pub2
35. Riley AJ, Goodman RE, Kellett JM, Orr R. Double Blind Trial of Yohimbine Hydrochloride in the Treatment of Erection Inadequacy.Sexual and Marital Therapy. 1989;4(1):17-26. doi:10.1080/02674658908407870
36. Coyne KS, Kvasz M, Ireland AM, Milsom I, Kopp ZS, Chapple CR. Urinary Incontinence and its Relationship to Mental Health and Health-Related Quality of Life in Men and Women in Sweden, the United Kingdom, and the United States.European Urology. 2012;61(1):88-95. doi:10.1016/j.eururo.2011.07.049
37. Stickley A, Santini ZI, Koyanagi A. Urinary incontinence, mental health and loneliness among community-dwelling older adults in Ireland.BMC Urol. 2017;17(1):29. doi:10.1186/s12894-017-0214-6
38. Choi EPH, Lam CLK, Chin WY. Mental health of Chinese primary care patients with lower urinary tract symptoms.Psychology, Health & Medicine. 2016;21(1):113-127. doi:10.1080/13548506.2015.1032309
39. Lee Hyeon, Rhee Y, Choi KS. Urinary incontinence and the association with depression, stress, and self-esteem in older Korean Women.Sci Rep. 2021;11(1):9054. doi:10.1038/s41598-021-88740-4
40. Stewart W, van Rooyen J, Cundiff G, et al. Prevalence and burden of overactive bladder in the United States.
World J Urol. 2003;20(6):327-336. doi:10.1007/s00345-002-0301-4
41. Coyne KS, Wein A, Nicholson S, Kvasz M, Chen CI, Milsom I. Comorbidities and personal burden of urgency urinary incontinence: a systematic review.Int J Clin Pract. 2013;67(10):1015-1033. doi:10.1111/ij cp.12164
42. Lee DM, Tetley J, Pendleton N. Urinary incontinence and sexual health in a population sample of older people.BJU Int. 2018;122(2):300-308. doi:10.1111/bju.14177
43. Abrams P, Smith AP, Cotterill N. The impact of urinary incontinence on health-related quality of life (HRQoL) in a real-world population of women aged 45-60 years: results from a survey in France, Germany, the UK and the USA.BJUInt. 2015;115(1):143-152. doi:10.1111/bju.12852
44. Steenstrup B, Lopes F, Cornu JN, Gilliaux M. Cognitive-behavioral therapy and urge urinary incontinence in women. A systematic review.Int Urogynecol J. 2022;33(5):1091-1101. doi:10.1007/s00192-021-04989-3
45. Anawalt DB. Causes of Male infertility.In: Post T, ed. UpToDate. UpToDate; 2022. Accessed May 28, 2022. http://www.uptodate.com
46. Evans J. ‘They are called Imperfect men’: Male Infertility and Sexual Health in Early Modern England.
Soc Hist Med. 2016;29(2):311-332. doi:10.1093/shm/hku073
47. Petok WD. Infertility counseling (or the lack thereof) of the forgotten male partner.Fertility and Sterility. 2015;104(2):260-266. doi:10.1016/j.fertnster t.2015.04.040
48. Smith JF, Walsh TJ, Shindel AW, et al. Sexual, marital, and social impact of a man's perceived infertility diagnosis.J Sex Med. 2009;6(9):2505-2515. doi:10.1111/j.1743-6109.2009.01383.x
49. Wang JY, Chen JD, Huang CC, et al. Investigation of time-dependent risk of mental disorders after infertility diagnosis, through survival analysis and data mining: a nationwide cohort study.The European Journal of Contraception & Reproductive Health Care. 2018;23(3):218-226. doi:10.1080/13625187.2018.1450972
50. Dooley M, Dineen T, Sarma K, Nolan A. The psychological impact of infertility and fertility treatment on the male partner.Human Fertility. 2014;17(3):203-209. doi:10.3109/14647273.2014.942390
51. Miner SA, Daumler D, Chan P, Gupta A, Lo K, Zelkowitz P. Masculinity, Mental Health, and Desire for Social Support Among Male Cancer and Infertility Patients.Am J Mens Health. 2019;13(1):155798831882039. doi:10.1177/1557988318820396
52. Nangia AK, Likosky DS, Wang D. Distribution of male infertility specialists in relation to the male population and assisted reproductive technology centers in the United States.Fertility and Sterility. 2010;94(2):599-609. doi:10.1016/j.fertnstert.2009.02.012
53. Peterson B, Boivin J, Norré J, Smith C, Thorn P, Wischmann T. An introduction to infertility counseling: a guide for mental health and medical professionals.J Assist Reprod Genet. 2012;29(3):243-248. doi:10.1007/s10815-011-9701-y
54. McVary KT. Epidemiology and pathophysiology of benign prostatic hyperplasia.In: Post T, ed. UpToDate. UpToDate; 2022. Accessed May 28, 2022. http://www.uptodate.com
55. Pinto JDO, He HG, Chan SWC, Toh PC, Esuvaranathan K, Wang W. Health-related quality of life and psychological well-being in patients with benign prostatic hyperplasia.J Clin Nurs. 2015;24(3-4):511-522. doi:10.1111/jocn.12636
56. Lee SU, Lee SH, So AH, et al. Association between benign prostatic hyperplasia and suicide in South Korea: A nationwide retrospective cohort study.PLoS ONE. 2022;17(3):e0265060. doi:10.1371/journal.pone.0265060
57. Pompili M, Magistri C, Maddalena S, Mellini C, Persechino S, Baldessarini RJ. Risk of Depression Associated With Finasteride Treatment.J Clin Psychopharmacol. 2021;41(3):304-309. doi:10.1097/jc p.0000000000001379
58. Sasibhushana RB, Shankaranarayana Rao BS, Srikumar BN. Repeated finasteride administration induces depression-like behavior in adult male rats.Behavioural Brain Research. 2019;365:185-189. doi:10.1016/j.bbr.2019.03.006
59. Erkoc M, Otunctemur A, Besiroglu H, Altunrende F. Evaluation of quality of life in patients undergoing surgery for benign prostatic hyperplasia.The Aging Male. 2018;21(4):238-242. doi:10.1080/13685538.2018.1433654
60. Evan AP, Worcester EM, Coe FL, Williams J Jr, Lingeman JE. Mechanisms of human kidney stone formation.
Urolithiasis. 2015;43(S1):19-32. doi:10.1007/s00240-014-0701-0
61. Raja A, Hekmati Z, Joshi HB. How Do Urinary Calculi Influence Health-Related Quality of Life and Patient Treatment Preference: A Systematic Review.Journal of Endourology. 2016;30(7):727-743. doi:10.1089/end.2016.0110
62. Raja A, Wood F, Joshi HB. The impact of urinary stone disease and their treatment on patients' quality of life: a qualitative study.Urolithiasis. 2020;48(3):227-234. doi:10.1007/s00240-019-01142-0
63. Penniston KL, Nakada SY. Development of an Instrument to Assess the Health Related Quality of Life of Kidney Stone Formers.Journal of Urology. 2013;189(3):921-930. doi:10.1016/j.juro.2012.08.247
64. Thelmo FL, Tzarnas S, Rosal NR, Kramer M, Walters L. Cystocerebral Syndrome: An Updated Review and a New Proposed Mechanism for an Often Forgotten Cause of Delirium.Cureus. Published online October 19, 2020. doi:10.7759/cureus.11034
65. Waardenburg IE. Delirium caused by urinary retention in elderly people: A case report and literature review on the “cystocerebral syndrome.”J Am Geriatr Soc. 2008;56(12):2371-2372. doi:10.1111/j.1532-5415.2008.02035.x